La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Behavioral effects of elevated expression of human equilibrative nucleoside transporter 1 in mice.

Identifieur interne : 001713 ( Main/Exploration ); précédent : 001712; suivant : 001714

Behavioral effects of elevated expression of human equilibrative nucleoside transporter 1 in mice.

Auteurs : Sara Kost [Canada] ; Chao Sun ; Wei Xiong ; Kathryn Graham ; Carol E. Cass ; James D. Young ; Benedict C. Albensi ; Fiona E. Parkinson

Source :

RBID : pubmed:21645551

English descriptors

Abstract

Adenosine concentrations are regulated by purinergic enzymes and nucleoside transporters. Transgenic mice with neuronal expression of human equilibrative nucleoside transporter 1 (hENT1) have been generated (Parkinson et al., 2009 [7]). The present study tested the hypothesis that mice homozygous and heterozygous for the transgene exhibit differences in hENT1 mRNA and protein expression, and in behavioral responses to caffeine and ethanol, two drugs with adenosine-dependent actions. Real time polymerase chain reaction (PCR) was used to identify mice heterozygous and homozygous for the transgene. Gene expression, determined by real time PCR of cDNA reverse transcribed from cerebral cortex RNA, was 3.8-fold greater in homozygous mice. Protein abundance, determined by radioligand binding assays using 0.14nM [(3)H]S-(4-nitrobenzyl)-6-thioinosine ([(3)H]NBTI), was up to 84% greater in cortex synaptosome membranes from homozygous than from heterozygous mice. In western blots with an antibody specific for hENT1, a protein of approximately 40kDa was strongly labelled in cortex samples from homozygous mice, weakly labelled in samples from heterozygous mice and absent from samples from wild type mice. In behavioral assays, transgenic mice showed a greater response to ethanol and a reduced response to caffeine than wild type littermates; however, no significant differences between heterozygous and homozygous mice were detected. These data indicate that the difference in ENT1 function between wild type and heterozygous mice was greater than that between heterozygous and homozygous mice. Therefore, either heterozygous or homozygous hENT1 transgenic mice can be used in studies of ENT1 regulation of adenosine levels and adenosine dependent behaviors.

DOI: 10.1016/j.bbr.2011.05.023
PubMed: 21645551


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Behavioral effects of elevated expression of human equilibrative nucleoside transporter 1 in mice.</title>
<author>
<name sortKey="Kost, Sara" sort="Kost, Sara" uniqKey="Kost S" first="Sara" last="Kost">Sara Kost</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba R3E 0T6, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba R3E 0T6</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sun, Chao" sort="Sun, Chao" uniqKey="Sun C" first="Chao" last="Sun">Chao Sun</name>
</author>
<author>
<name sortKey="Xiong, Wei" sort="Xiong, Wei" uniqKey="Xiong W" first="Wei" last="Xiong">Wei Xiong</name>
</author>
<author>
<name sortKey="Graham, Kathryn" sort="Graham, Kathryn" uniqKey="Graham K" first="Kathryn" last="Graham">Kathryn Graham</name>
</author>
<author>
<name sortKey="Cass, Carol E" sort="Cass, Carol E" uniqKey="Cass C" first="Carol E" last="Cass">Carol E. Cass</name>
</author>
<author>
<name sortKey="Young, James D" sort="Young, James D" uniqKey="Young J" first="James D" last="Young">James D. Young</name>
</author>
<author>
<name sortKey="Albensi, Benedict C" sort="Albensi, Benedict C" uniqKey="Albensi B" first="Benedict C" last="Albensi">Benedict C. Albensi</name>
</author>
<author>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E" last="Parkinson">Fiona E. Parkinson</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21645551</idno>
<idno type="pmid">21645551</idno>
<idno type="doi">10.1016/j.bbr.2011.05.023</idno>
<idno type="wicri:Area/PubMed/Corpus">000B64</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000B64</idno>
<idno type="wicri:Area/PubMed/Curation">000B64</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000B64</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000B64</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000B64</idno>
<idno type="wicri:Area/Ncbi/Merge">000E91</idno>
<idno type="wicri:Area/Ncbi/Curation">000E91</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000E91</idno>
<idno type="wicri:Area/Main/Merge">001785</idno>
<idno type="wicri:Area/Main/Curation">001713</idno>
<idno type="wicri:Area/Main/Exploration">001713</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Behavioral effects of elevated expression of human equilibrative nucleoside transporter 1 in mice.</title>
<author>
<name sortKey="Kost, Sara" sort="Kost, Sara" uniqKey="Kost S" first="Sara" last="Kost">Sara Kost</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba R3E 0T6, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba R3E 0T6</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sun, Chao" sort="Sun, Chao" uniqKey="Sun C" first="Chao" last="Sun">Chao Sun</name>
</author>
<author>
<name sortKey="Xiong, Wei" sort="Xiong, Wei" uniqKey="Xiong W" first="Wei" last="Xiong">Wei Xiong</name>
</author>
<author>
<name sortKey="Graham, Kathryn" sort="Graham, Kathryn" uniqKey="Graham K" first="Kathryn" last="Graham">Kathryn Graham</name>
</author>
<author>
<name sortKey="Cass, Carol E" sort="Cass, Carol E" uniqKey="Cass C" first="Carol E" last="Cass">Carol E. Cass</name>
</author>
<author>
<name sortKey="Young, James D" sort="Young, James D" uniqKey="Young J" first="James D" last="Young">James D. Young</name>
</author>
<author>
<name sortKey="Albensi, Benedict C" sort="Albensi, Benedict C" uniqKey="Albensi B" first="Benedict C" last="Albensi">Benedict C. Albensi</name>
</author>
<author>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E" last="Parkinson">Fiona E. Parkinson</name>
</author>
</analytic>
<series>
<title level="j">Behavioural brain research</title>
<idno type="eISSN">1872-7549</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adenosine Kinase (genetics)</term>
<term>Adenosine Kinase (metabolism)</term>
<term>Analysis of Variance</term>
<term>Animals</term>
<term>Behavior, Animal (drug effects)</term>
<term>Behavior, Animal (physiology)</term>
<term>Caffeine (pharmacology)</term>
<term>Cerebral Cortex (metabolism)</term>
<term>Equilibrative Nucleoside Transporter 1 (genetics)</term>
<term>Equilibrative Nucleoside Transporter 1 (metabolism)</term>
<term>Ethanol (pharmacology)</term>
<term>Gene Expression Regulation (genetics)</term>
<term>Humans</term>
<term>Mice</term>
<term>Mice, Transgenic</term>
<term>Motor Activity (drug effects)</term>
<term>Motor Activity (genetics)</term>
<term>Protein Binding (drug effects)</term>
<term>Protein Binding (genetics)</term>
<term>Thioinosine (analogs & derivatives)</term>
<term>Thioinosine (pharmacokinetics)</term>
<term>Tritium (pharmacokinetics)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Thioinosine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Adenosine Kinase</term>
<term>Equilibrative Nucleoside Transporter 1</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Adenosine Kinase</term>
<term>Equilibrative Nucleoside Transporter 1</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Behavior, Animal</term>
<term>Motor Activity</term>
<term>Protein Binding</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Gene Expression Regulation</term>
<term>Motor Activity</term>
<term>Protein Binding</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Cerebral Cortex</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en">
<term>Thioinosine</term>
<term>Tritium</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Caffeine</term>
<term>Ethanol</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Behavior, Animal</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Analysis of Variance</term>
<term>Animals</term>
<term>Humans</term>
<term>Mice</term>
<term>Mice, Transgenic</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Adenosine concentrations are regulated by purinergic enzymes and nucleoside transporters. Transgenic mice with neuronal expression of human equilibrative nucleoside transporter 1 (hENT1) have been generated (Parkinson et al., 2009 [7]). The present study tested the hypothesis that mice homozygous and heterozygous for the transgene exhibit differences in hENT1 mRNA and protein expression, and in behavioral responses to caffeine and ethanol, two drugs with adenosine-dependent actions. Real time polymerase chain reaction (PCR) was used to identify mice heterozygous and homozygous for the transgene. Gene expression, determined by real time PCR of cDNA reverse transcribed from cerebral cortex RNA, was 3.8-fold greater in homozygous mice. Protein abundance, determined by radioligand binding assays using 0.14nM [(3)H]S-(4-nitrobenzyl)-6-thioinosine ([(3)H]NBTI), was up to 84% greater in cortex synaptosome membranes from homozygous than from heterozygous mice. In western blots with an antibody specific for hENT1, a protein of approximately 40kDa was strongly labelled in cortex samples from homozygous mice, weakly labelled in samples from heterozygous mice and absent from samples from wild type mice. In behavioral assays, transgenic mice showed a greater response to ethanol and a reduced response to caffeine than wild type littermates; however, no significant differences between heterozygous and homozygous mice were detected. These data indicate that the difference in ENT1 function between wild type and heterozygous mice was greater than that between heterozygous and homozygous mice. Therefore, either heterozygous or homozygous hENT1 transgenic mice can be used in studies of ENT1 regulation of adenosine levels and adenosine dependent behaviors.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
<region>
<li>Manitoba</li>
</region>
<settlement>
<li>Winnipeg</li>
</settlement>
<orgName>
<li>Université du Manitoba</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Albensi, Benedict C" sort="Albensi, Benedict C" uniqKey="Albensi B" first="Benedict C" last="Albensi">Benedict C. Albensi</name>
<name sortKey="Cass, Carol E" sort="Cass, Carol E" uniqKey="Cass C" first="Carol E" last="Cass">Carol E. Cass</name>
<name sortKey="Graham, Kathryn" sort="Graham, Kathryn" uniqKey="Graham K" first="Kathryn" last="Graham">Kathryn Graham</name>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E" last="Parkinson">Fiona E. Parkinson</name>
<name sortKey="Sun, Chao" sort="Sun, Chao" uniqKey="Sun C" first="Chao" last="Sun">Chao Sun</name>
<name sortKey="Xiong, Wei" sort="Xiong, Wei" uniqKey="Xiong W" first="Wei" last="Xiong">Wei Xiong</name>
<name sortKey="Young, James D" sort="Young, James D" uniqKey="Young J" first="James D" last="Young">James D. Young</name>
</noCountry>
<country name="Canada">
<region name="Manitoba">
<name sortKey="Kost, Sara" sort="Kost, Sara" uniqKey="Kost S" first="Sara" last="Kost">Sara Kost</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001713 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001713 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21645551
   |texte=   Behavioral effects of elevated expression of human equilibrative nucleoside transporter 1 in mice.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21645551" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022